Cholinergic Drugs

CHOLINERGIC DRUGS

Description also available in video format (attached below), for better experience use your desktop.

IntroductionTop of FormTop of Form

·       Cholinergic drugs, also known as cholinomimetics, are a class of medications that mimic the action of acetylcholine (ACh), a neurotransmitter in both the central and peripheral nervous systems.

·       These drugs play a crucial role in managing various medical conditions by influencing the cholinergic system.

Definition

·       Cholinergic drugs are substances that either enhance the action of acetylcholine or inhibit its breakdown.

1.     Direct-acting cholinergic agonists: These drugs bind directly to cholinergic receptors and mimic the action of acetylcholine.

2.     Indirect-acting cholinergic agonists: These drugs increase the levels of acetylcholine by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine.

Classification

1.     Direct-acting Cholinergic Agonists:

·        Examples: Bethanechol, Pilocarpine, Carbachol

·        Uses: Treating urinary retention, glaucoma, and dry mouth.

2.     Indirect-acting Cholinergic Agonists (Anticholinesterases):

·        Examples: Neostigmine, Physostigmine, Donepezil, Rivastigmine

·        Uses: Managing myasthenia gravis, Alzheimer's disease, and as antidotes for anticholinergic poisoning.

Pharmacokinetics

·        Absorption: Cholinergic drugs can be administered orally, intravenously, subcutaneously, or topically. Their absorption rate depends on the route of administration.

·        Distribution: These drugs are distributed throughout the body and can cross the blood-brain barrier, especially indirect-acting cholinergic drugs like donepezil.

·        Metabolism: Primarily metabolized by the liver. For example, acetylcholinesterase inhibitors are often hydrolyzed by plasma cholinesterase's and hepatic enzymes.

·        Excretion: Mainly excreted via the kidneys. The elimination half-life varies among different drugs, influencing dosing frequency.

Mechanism of Action

·        Direct-acting Cholinergic Agonists: Bind directly to muscarinic or nicotinic receptors, activating them and producing physiological effects similar to acetylcholine.

·        Indirect-acting Cholinergic Agonists: Inhibit acetylcholinesterase, preventing the breakdown of acetylcholine and thereby increasing its concentration and duration of action at cholinergic synapses.

Uses

·        Bethanechol: Used to treat urinary retention by stimulating bladder contractions.

·        Pilocarpine: Utilized in glaucoma treatment to reduce intraocular pressure and to treat dry mouth in Sjogren's syndrome.

·        Neostigmine: Employed in the management of myasthenia gravis and as a reversal agent for non-depolarizing neuromuscular blockers.

·        Donepezil: Prescribed for symptomatic treatment of Alzheimer's disease to enhance cognitive function.

Adverse Effects

·        Nausea

·        Vomiting

·        Diarrhea

·        Abdominal cramps

·        Increased salivation

·        Sweating

·        Bradycardia (slow heart rate)

·        Hypotension (low blood pressure)

·        Bronchoconstriction

Contraindications

·        Asthma or chronic obstructive pulmonary disease (COPD)

·        Bradycardia

·        Peptic ulcer disease

·        Hyperthyroidism

·        Urinary tract obstruction

·        Gastrointestinal obstruction

Role of the Nurse

1.     Assessment:

·        Obtain a thorough medical history, including any conditions that contraindicate cholinergic drug use.

·        Monitor vital signs, especially heart rate and blood pressure.

2.     Administration:

·        Administer the medication as prescribed, considering the specific route and timing.

·        Ensure proper technique in cases of intravenous or subcutaneous administration.

3.     Patient Education:

·        Educate patients on the purpose of the medication, possible side effects, and the importance of adherence to the prescribed regimen.

·        Advise patients on potential interactions with other medications and substances.

4.     Monitoring and Follow-up:

·        Regularly monitor patients for therapeutic effects and adverse reactions.

·        Report and document any side effects or complications.

·        Adjust treatment plans based on the patient's response and any changes in condition.

5.     Support and Advocacy:

·        Provide emotional support and reassurance to patients, particularly those with chronic conditions.

·        Advocate for the patient's needs and preferences in their treatment plan.

Video Description

·       Don’t forget to do these things if you get benefitted from this article

o   Visit our Let’s contribute page https://keedainformation.blogspot.com/p/lets-contribute.html

o   Follow our page

o   Like & comment on our post

·